Every one of those 1 sits in a single category, medical-devices. Dr. Avinashdev Upadhyay is most often covered alongside Avascular Necrosis (AVN), which appears in 1 of these 1 story. At 5, the average consequence score sits below the same-window beat average of 5.2.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Dr. Avinashdev Upadhyay
Every one of those 1 sits in a single category, medical-devices. Dr. Avinashdev Upadhyay is most often covered alongside Avascular Necrosis (AVN), which appears in 1 of these 1 story. At 5, the average consequence score sits below the same-window beat average of 5.2. Source depth averages 2 original sources per story, versus 2.2 across the same-window beat baseline. Dr. Avinashdev Upadhyay appears in 1 tracked Healthcare story from August 12, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 40 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Dr. Avinashdev Upadhyay. Shared-story counts are live from our verified record — not editorial picks.
UMC Hospitals announced the first robotic direct anterior total hip replacement on a 67-year-old patient with advanced avascular necrosis. The case signals the spread of robotic musculoskeletal surgery into India’s tier‑2 cities, raising the bar for min invasive joint care.